Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3718583019 | Hydrochlorothiazide- and triamterene-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3718584013 | Product containing hydrochlorothiazide and triamterene in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5529761000241119 | produit contenant de l'hydrochlorothiazide et du triamtérène sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Has active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Is a | Product containing triamterene in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Is a | Product containing hydrochlorothiazide and triamterene (medicinal product) | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Has active ingredient | Triamterene (substance) | true | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Is a | Hydrochlorothiazide-containing product in oral dose form | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and triamterene-containing product in oral dose form | Plays role | Potassium-sparing diuretic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydrochlorothiazide and triamterene only product in oral dose form | Is a | True | Hydrochlorothiazide- and triamterene-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR